• 2023/01/10
  We were granted a patent for “a composition for treatment of intractable neurological diseases and its manufacturing method”.
• 2022/11/29
  【 Research Bulletin 】SAISEIKEN Co.,Ltd. is pleased to announce that the following paper was submitted to an international scientific journal ( Cytotherapy ) on 2022/11/23.
• 2022/06/21
  A new paper was published on 21 June, World ALS/MND Day.

BUSINESS

Scope of business

Company overview

Intellectual property

Research and development